243 related articles for article (PubMed ID: 16909022)
1. Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.
Guillemin GJ; Meininger V; Brew BJ
Neurodegener Dis; 2005; 2(3-4):166-76. PubMed ID: 16909022
[TBL] [Abstract][Full Text] [Related]
2. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ
Neuropharmacology; 2017 Jan; 112(Pt B):346-364. PubMed ID: 27265569
[TBL] [Abstract][Full Text] [Related]
3. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.
Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan S; Grant R; Brew BJ; Guillemin GJ
Neurotox Res; 2010 Aug; 18(2):132-42. PubMed ID: 19921535
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.
Chen Y; Brew BJ; Guillemin GJ
J Neurochem; 2011 Sep; 118(5):816-25. PubMed ID: 21182524
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors.
Chen Y; Meininger V; Guillemin GJ
Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):32-9. PubMed ID: 20021336
[TBL] [Abstract][Full Text] [Related]
6. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease.
Guillemin GJ; Brew BJ
Redox Rep; 2002; 7(4):199-206. PubMed ID: 12396664
[TBL] [Abstract][Full Text] [Related]
7. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
8. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
Guillemin GJ; Smythe G; Takikawa O; Brew BJ
Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.
Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ
Redox Rep; 2000; 5(2-3):108-11. PubMed ID: 10939285
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ
J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905
[TBL] [Abstract][Full Text] [Related]
11. Expression of the kynurenine pathway enzymes in human microglia and macrophages.
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ
Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722
[TBL] [Abstract][Full Text] [Related]
12. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
13. Effect of wedelolactone and gallic acid on quinolinic acid-induced neurotoxicity and impaired motor function: significance to sporadic amyotrophic lateral sclerosis.
S M; T P; Goli D
Neurotoxicology; 2018 Sep; 68():1-12. PubMed ID: 29981346
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART.
Drewes JL; Meulendyke KA; Liao Z; Witwer KW; Gama L; Ubaida-Mohien C; Li M; Notarangelo FM; Tarwater PM; Schwarcz R; Graham DR; Zink MC
J Neurovirol; 2015 Aug; 21(4):449-63. PubMed ID: 25776527
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.
Guillemin GJ; Brew BJ; Noonan CE; Takikawa O; Cullen KM
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):395-404. PubMed ID: 16008823
[TBL] [Abstract][Full Text] [Related]
16. Anti-ALS activity of alsin, the product of the ALS2 gene, and activity-dependent neurotrophic factor.
Matsuoka M; Nishimoto I
Neurodegener Dis; 2005; 2(3-4):135-8. PubMed ID: 16909018
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
18. Neuroscience. Astrocytes secrete substance that kills motor neurons in ALS.
Holden C
Science; 2007 Apr; 316(5823):353. PubMed ID: 17446359
[No Abstract] [Full Text] [Related]
19. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
Pehar M; Cassina P; Vargas MR; Castellanos R; Viera L; Beckman JS; Estévez AG; Barbeito L
J Neurochem; 2004 Apr; 89(2):464-73. PubMed ID: 15056289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
